Latest News
Pfizer (PFE) Acquires ReViral for $525M to Strengthen RSV Endeavour
Key points: Pfizer acquires ReViral for a total sum of $525M, including development milestones The move strengthens the company's work towards respiratory syncytial virus (RSV)

Erytech Stock Leaps 50% On Haematology Publication – Why?
Key points: Erytech Pharma might have a real product on its hands This is the goal for every pharma development company This is not proof, yet, but it’s a valuation event

Omega Diagnostics (ODX) Shares Plunged 12.7% After Its Annual Update
Key points: Omega Diagnostics (ODX) shares plunged 12.7% on its annual update. Investors ignored the significant surge in its revenues compared to 2020. However, the

Greatland Gold, GGP, Flatlines On Scallywag – What Will Move It?
Key points: Greatland Gold has announced the results from the Scallywag programme The share price is pretty much flatlining The reason might be the results aren’t all that

Vela Technologies Shares Have Risen 9.33% in One Month. Is It a Buy?
Key points: Vela Technologies shares have risen 9.33% in one month. Are they a buy? The company recently acquired shares in Igraine, a med-tech investment firm. Vela

Imperial Brands, IMB, Shares Fade Back After Trading Update, What Now?
Key points: Imperial Brands shares have faded back ½% after yesterday’s 3% rise The announcement was of their trading update Imperial is on track to hit revised full-year

Cloudbreak Discovery Shares, CDL, Up 10% As Dealmaking Returns?
Key points: Cloudbreak Discovery shares are up 10% on the back of a deal announcement This time it’s oil and gas in Namibia It’s likely deals that drive the Cloudbreak sha

Mullen Automotive (MULN); Another EV Fraud? Hindenburg Think So…
Key points: Mullen Automotive becomes the target for notorious short-seller Hindenburg Research They claim the company has misled investors on multiple occasions, including batte

System1 (SST) Is ‘More Than a Meme’, Will The SST Rally Continue?
Key points: System1 surged over 100% on strong Q4 earnings P/E ratio currently sits at an astronomical 66X Benchmark analyst argues the stock is 'much more than a mem

Mobiquity (MOBQ) Stock Soared by 69.3% on A-Nation Advertising Deal
Key points: Mobiquity stock soared 69.3% on A-Nation data and advertising deal. The companies did not disclose the financial details of the partnership. Investors ch

Ripple Price Prediction: What’s Next for XRP After a 7.77% Weekly Drop?
Key points: Ripple prices have fallen 7.77% in one week as its recent rally subsides. The XRP network has significant uses in global cross-border payments. However,

Rivian (RIVN) Stock Sells Off Despite On-Track Production, Here’s Why
Key points: Rivian re-affirms FY22 production guidance following on-track Q1 production RIVN stock continues to show strong selling pressure as investors still aren't convinced

Boeing (BA) Expands Digital Footprint With These Key Cloud Giants
Key points: Boeing step up cloud-computing game with three industry giants; Google, Amazon and Microsoft Company hopes to improve 'global scalability and elasticity' through the

Uber Stock Surges Higher As the Company Expands Its Services
Key points: Uber stock has risen by 17.2% in one month due to a broad recovery. However, Uber’s story could be more than just a sectoral recovery. The firm is expand

Sareum Shares Rallied 18.2% Despite a Lack of News. Here’s Why.
Key points: Sareum shares rallied 18.2% without any news releases from the firm. As a result, investors were left wondering what triggered the move. Read on to find

JetBlue Swoop in on Acquisition of Spirit Airlines in ‘Low Cost’ Mission
Key points: JetBlue announced on Tuesday its $3.6B bif for ultra low-cost Spirit Airlines The company hopes to expand its flight paths to attract larger numbers of leisure travel

Dakota Gold, DC, Leaps 100% On Listing Move – More To Come?
Key points: Dakota Gold has moved from the OTCQB market to NYSE American This was combined with a merger with the controlling shareholder, JR Resources The result today is

Genedrive (GDR) Shares Have Risen 171.9% in a Month. What’s Next?
Key points: Genedrive shares have risen 171.9% in one month. So, what’s next? The company’s hearing loss test targeted at babies is behind the rally. In addition, th

Redrow Caps Cladding Compensation – Is This Really Over?
Key points: Redrow hopes it has capped the cladding compensation bill £164 million provision to come for remedial work Is this really going to be the end of the story?
